VALE WYLIE W 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Sep 3, 2004
Insider Transaction Report
Form 4
VALE WYLIE W
Director
Transactions
- Sale
Common Stock
2004-09-01$50.07/sh−1,400$70,098→ 288,672 total - Sale
Common Stock
2004-09-01$50.11/sh−900$45,099→ 290,472 total - Sale
Common Stock
2004-09-01$50.10/sh−200$10,020→ 290,272 total - Sale
Common Stock
2004-09-01$50.03/sh−1,500$75,045→ 286,672 total - Sale
Common Stock
2004-09-01$50.02/sh−100$5,002→ 286,372 total - Sale
Common Stock
2004-09-01$50.01/sh−2,000$100,020→ 284,372 total - Sale
Common Stock
2004-09-01$50.00/sh−3,000$150,000→ 281,372 total - Sale
Common Stock
2004-09-01$50.05/sh−500$25,025→ 288,172 total
Footnotes (2)
- [F1]The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person and delivered to the broker on February 11, 2004.
- [F2]205,630 shares are held by the Reporting Person; 75,742 shares held indirectly by WBV Limited Liability Company.